Biotricity, Inc.
BTCY
$0.25
$0.0312.92%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.99M | 3.89M | 3.87M | 3.70M | 3.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.99M | 3.89M | 3.87M | 3.70M | 3.62M |
| Cost of Revenue | 736.30K | 704.30K | 757.20K | 724.40K | 855.10K |
| Gross Profit | 3.25M | 3.18M | 3.12M | 2.98M | 2.76M |
| SG&A Expenses | 2.19M | 2.30M | 2.14M | 3.26M | 2.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.55M | 3.61M | 3.59M | 4.56M | 3.79M |
| Operating Income | 440.90K | 273.80K | 281.90K | -855.50K | -169.00K |
| Income Before Tax | -717.10K | -690.90K | -672.00K | -1.94M | -1.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -717.10K | -690.90K | -672.00K | -1.94M | -1.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -717.10K | -690.90K | -672.00K | -1.94M | -1.23M |
| EBIT | 440.90K | 273.80K | 281.90K | -855.50K | -169.00K |
| EBITDA | 442.40K | 275.30K | 283.40K | -854.00K | -167.50K |
| EPS Basic | -0.04 | -0.03 | -0.03 | -0.08 | -0.05 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.05 | -0.03 |
| EPS Diluted | -0.04 | -0.03 | -0.03 | -0.08 | -0.05 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.05 | -0.03 |
| Average Basic Shares Outstanding | 27.59M | 26.77M | 26.28M | 26.35M | 24.23M |
| Average Diluted Shares Outstanding | 27.59M | 26.77M | 26.28M | 26.35M | 24.23M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.84% | -0.89% | -0.88% | -0.32% | -0.48% |